Salesforce Shares Surge as AI Demand Powers Q2 Earnings Beat 
Amazon Secures 200 MW Wind Power Deals in Sweden 
Nvidia Reportedly Eyes $13 Billion Hugging Face Acquisition 
Shein Hong Kong IPO to Raise $1.7 Billion at $26.5 Billion Valuation 
PayPal Shares Sink as $50 Billion Takeover Bid Collapses 
Trian Drops Wendy’s Take-Private Bid Plans, Shares Plunge 14% 
BNP Paribas, KB Kookmin Eye $2 Billion Techcombank Stake 
Honda, Nissan Eye Shared Vehicle Software Platform by 2029 
Meta, U.S. States Discuss Settlement in Teen Addiction Trial 
SK Biopharmaceuticals Secures Global Rights to Biohaven Epilepsy Drug Opakalim 
Pinterest Stock Falls as CFO Julia Brau Donnelly Resigns 
Mercer International Stock Surges 45% on C$20 Million Canada Funding 
BofA Names ASML Top Semiconductor Equipment Pick on Growth, Valuation 
Nvidia Pauses AI Cloud Financing Deals Amid Antitrust Concerns 
OpenAI Data Center Chief Chris Malone Exits Ahead of Planned 2027 Listing 
HP Stock Drops 9% Despite Q3 Earnings Beat and Raised 2026 Outlook 
Nvidia Revenue Soars 106% as AI Demand Hits ‘Inflection Point’ 
Add as a preferred source on Google
CLEVELAND, April 12, 2018 -- Athersys, Inc. (Nasdaq:ATHX) will release its first quarter 2018 financial results at approximately 4:00 PM Eastern Time on Thursday, May 10, 2018, and will host a conference call shortly thereafter at 4:30 PM Eastern Time to review the results. Gil Van Bokkelen, Chairman and Chief Executive Officer, and William (B.J.) Lehmann, President and Chief Operating Officer, will host the call as follows:
| Date | May 10, 2018 |
| Time | 4:30 p.m. (Eastern Time) |
| Telephone access: US and Canada | (800) 273-1254 |
| Telephone access: International | (973) 638-3440 |
| Access code | 1189915 |
| Live webcast | www.athersys.com under Investors section |
A replay will be available for on-demand listening shortly after the completion of the call until 11:59 PM Eastern Time on May 24, 2018 at the aforementioned URL, or by dialing (800) 585-8367 or (855) 859-2056 in the U.S. and Canada, or from abroad (404) 537-3406, and entering access code 1189915.
About Athersys
Athersys is an international biotechnology company engaged in the discovery and development of therapeutic product candidates designed to extend and enhance the quality of human life. The Company is developing its MultiStem® cell therapy product, a patented, adult-derived "off-the-shelf" stem cell product, initially for disease indications in the neurological, cardiovascular, and inflammatory and immune disease areas, and has several ongoing clinical trials evaluating this potential regenerative medicine product. Athersys has forged strategic partnerships and a broad network of collaborations to further advance the MultiStem cell therapy toward commercialization. More information is available at www.athersys.com.
ATHX-G
Contact:
William (B.J.) Lehmann, J.D.
President and Chief Operating Officer
Tel: (216) 431-9900
[email protected]
Karen Hunady
Corporate Communications and Investor Relations
Tel: (216) 431-9900
[email protected]
David Schull
Russo Partners, LLC
Tel: (212) 845-4271 or (858) 717-2310
[email protected]
